Cross-Sector entity

Indian Institute of Technology Bombay (IIT Bombay)

academic institution
7

All 1 tracked stories fall under one category: pharma. Indian Institute of Technology Bombay (IIT Bombay) is most often covered alongside Biofabrication, which appears in 1 of these 1 story. We currently track 1 Cross-Sector story that mention Indian Institute of Technology Bombay (IIT Bombay), all published on July 5, 2026.

1 verified story tracked

Last mentioned: Jul 5, 2026

Entity pulse

Recent coverage · Indian Institute of Technology Bombay (IIT Bombay)

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Indian Institute of Technology Bombay (IIT Bombay)

All 1 tracked stories fall under one category: pharma. Indian Institute of Technology Bombay (IIT Bombay) is most often covered alongside Biofabrication, which appears in 1 of these 1 story. We currently track 1 Cross-Sector story that mention Indian Institute of Technology Bombay (IIT Bombay), all published on July 5, 2026. Each carries 5 original sources on average.

Stories tracked
1
Sources per story
5

Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Indian Institute of Technology Bombay (IIT Bombay). Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Indian Institute of Technology Bombay (IIT Bombay) 1

Biotech pharma Positive 7

Indian Placenta-on-Chip Replicates 4 Functions for Drug R&D

Indian researchers have developed a placenta-on-chip that replicates four key maternal-fetal barrier functions—hormone production, glucose transport, urea clearance, and selective permeability—offering pharma a scalable tool for drug safety screening. The device’s response to hyperglycemic conditions mimics gestational diabetes, and its design using conventional well plates enables wide adoption across pharmaceutical R&D labs, potentially cutting costs and accelerating regulatory-required fetal toxicity assessments.

5 sources